No price history available.
Key financial summary
Financials in EUR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | €m | 11 | 9 | 9 | 14 | 13 | 12 | N/A | N/A |
| Operating profit | €m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | €m | -1 | -0 | 1 | 2 | 1 | 1 | N/A | N/A |
| EPS reported | € | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | € | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | € | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | € | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | €m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | €m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | €m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | € | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | € | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in EUR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Memscap, S.A. is a Crolles, France-based company, founded in 1997, that develops and delivers advanced micro-electro-mechanical systems (MEMS) solutions. Catering to a global clientele, the company serves diverse sectors including aerospace and defense, optical communication, medical and biomedical, and information technology/consumer electronics. Their extensive product catalog includes a variety of pressure sensing devices, such as sensors, transducers, and switches. These are crucial for applications ranging from air data computers, cabin pressure management, and engine control systems to altimeters, barometers, and cockpit instrumentation, as well as air data test sets. Additionally, they supply specialized gold-coated and titanium-based pressure transducers, along with accessories like plastic domes and line-sets, and offer magnetic switches/relays. In the medical domain, Memscap manufactures implantable pressure sensors vital for monitoring conditions like spinal pressure and abdominal aortic aneurysms. For the optical telecommunications industry, the company supplies optical MEMS chips integral to variable optical attenuators. Beyond products, Memscap offers a comprehensive suite of multi-user MEMS processes (MUMPs), including PolyMUMPs, SOIMUMPs, and PiezoMUMPs, complemented by MUMPs-PLUS and various post-processing services. They also cater to specific client needs through custom products, encompassing wafers, MEMS dies, and wafer-level packaged devices, alongside providing full manufacturing and prototyping services. Memscap's clientele spans Fortune 500 corporations, leading high-technology enterprises, esteemed research institutions, and academic universities.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
Memscap, S.A. is a Crolles, France-based company, founded in 1997, that develops and delivers advanced micro-electro-mechanical systems (MEMS) solutions. Catering to a global clientele, the company serves diverse sectors including aerospace and defense, optical communication, medical and biomedical, and information technology/consumer electronics. Their extensive product catalog includes a variety of pressure sensing devices, such as sensors, transducers, and switches. These are crucial for applications ranging from air data computers, cabin pressure management, and engine control systems to altimeters, barometers, and cockpit instrumentation, as well as air data test sets. Additionally, they supply specialized gold-coated and titanium-based pressure transducers, along with accessories like plastic domes and line-sets, and offer magnetic switches/relays. In the medical domain, Memscap manufactures implantable pressure sensors vital for monitoring conditions like spinal pressure and abdominal aortic aneurysms. For the optical telecommunications industry, the company supplies optical MEMS chips integral to variable optical attenuators. Beyond products, Memscap offers a comprehensive suite of multi-user MEMS processes (MUMPs), including PolyMUMPs, SOIMUMPs, and PiezoMUMPs, complemented by MUMPs-PLUS and various post-processing services. They also cater to specific client needs through custom products, encompassing wafers, MEMS dies, and wafer-level packaged devices, alongside providing full manufacturing and prototyping services. Memscap's clientele spans Fortune 500 corporations, leading high-technology enterprises, esteemed research institutions, and academic universities.
